Researchs
-
Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi
-
Michigan State University College of Osteopathic Medicine Medical Scientist Training Program (MSTP)
-
Additional service of Physician Reviewer for the State of Michigan Department of Health and Human Services effective 10/1/20
-
The Epidemiology of Concussions in Ivy League and Big Ten Sports
-
Visualizing Brain Proteinopathies Using [F-18] Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment with Either Suspected Chronic Traumatic Encephalopathy or Alzh
-
Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneurop
-
MSU Department of Neurology MDA Care Center
-
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies
-
Eisai BAN2401-G000-201 Open Label Extension
-
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis
-
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with
-
A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan inSubjects with Generalized Myasthenia Gravis
-
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharma
-
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis
-
A PHASE 2, RANDOMIZED, BLINDED, PLACEBOCONTROLLED,STUDY TO EVALUATE SAFETY,TOLERABILITY, PHARMACOMETRICS, ANDEFFICACY OF DNTH103 IN ADULTS WITHGENERALIZED MYASTHENIA GRAVIS (MAGIC)
-
A Phase 2 Trial to Investigate the Efficacy, Safety and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ADHERE)
-
Establishing a Baseline for Multilingual Capabilities of Medical Residents
-
Nanoparticle antagonism of tumor-associated immunosuppression to improve breast cancer therapy
-
School Based Substance Misuse Awareness and Prevention Approach
-
MI-CARES (SOR3)